Pharmacists in Mc Cook, NE Accepting Medicare

8 Pharmacists found. Showing 1 - 8

Chris Farrell, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 120 W B St, Mc Cook, NE 69001 Phone: 308-345-1781    Fax: 308-345-3967

Elizabeth A Neal, PHARMD Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 902 N Highway 83, Mc Cook, NE 69001 Phone: 308-345-5670    Fax: 308-345-5676

Yuri Lee Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1902 W B St, Mc Cook, NE 69001 Phone: 308-345-7024

Megan Lea Taylor Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1902 W B St, Mc Cook, NE 69001 Phone: 308-345-7024    Fax: 308-345-8039

Mrs. Maria C Heapy, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 205 Norris Ave, Mc Cook, NE 69001 Phone: 308-345-2560    Fax: 308-345-1947

Mrs. Angela E Langan, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 902 N Highway 83, Mc Cook, NE 69001 Phone: 308-345-2560    Fax: 308-345-1947

Mr. Ronald Dale Stuhmer, BC HIS RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 322 Norris Ave Ste 5a, Mc Cook, NE 69001 Phone: 308-345-4653

Dr. Chase Crawford, PHARMD, BCPS Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 1301 E H St, Mc Cook, NE 69001 Phone: 308-344-8258    Fax: 308-344-8558

News Archive

UCLA researchers identify chemical changes in brains of patients with early-onset Alzheimer's

With a lack of effective treatments for Alzheimer's, most of us would think long and hard about whether we wanted to know years in advance if we were genetically predisposed to develop the disease. For researchers, however, such knowledge is a window into Alzheimer's disease's evolution.

LLS, FORMA Therapeutics collaborate to develop small molecule compounds against Bcl-6

The Leukemia & Lymphoma Society and FORMA Therapeutics, Inc., today announced they have begun a partnership to discover and develop small molecule compounds against a key lymphoma target, Bcl-6.

SXC collaborates with Allscripts to enhance e-prescribing solutions

SXC Health Solutions Corp. ("SXC" or the "Company") (NASDAQ: SXCI, TSX: SXC), today announced it has entered into a strategic relationship with Allscripts (NASDAQ: MDRX) to enhance the electronic prescribing (e-prescribing) options available to SXC's healthcare benefits management customers.

Fluoxetine increases offensive aggression and alters brain development in adolescent hamsters

Fluoxetine was the first drug approved by the FDA for major depressive disorder (MDD) in children and adolescents, and to this date, it remains one of only two selective serotonin reuptake inhibitors (SSRIs) registered for treatment of MDD in children and adolescents, despite reports that indicate this class of drugs is associated with side effects, such as agitation, hostility and aggression.

Read more Medical News

› Verified 9 days ago